Composition of the Global HIV Prevention R&D Investment Base, 2015-2016

Embed Download PDF Download Image

The call for a more diverse base of funders in the prevention R&D landscape is not a new one, but recent trends display greater polarization and a more extreme funding imbalance. In 2016, 75 percent of the overall funding came from the US public sector. Together, the US public sector and the BMGF represented 88 percent of the total global investment in 2016, compared to 81 percent in 2015.

Excerpted from our HIV prevention research tracking report, visit here for all graphics from the report.

Tracking and Translating the Field